Risk scoring for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Beswick, Andrew ^a   Brindle, P ^b   Ebrahim, S ^b   Fahey, T ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; HUMAN; OUTCOME ASSESSMENT; PROPHYLAXIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT;

EID: 44949260002     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006887     Document Type: Review

References (12)

1. Anderson 1991 Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. American Heart Journal 1991;121(1 Pt 2):293-8.
2. Assmann 2002 Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105(3):310-5.
3. Beswick 2006 Beswick A, Brindle P. Risk scoring in the assessment of cardiovascular risk. Current Opinion in Lipidology 2006;17(4):375-86.
4. Brindle 2006 Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92(12):1752-9.
5. Conroy 2003 Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al.Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. European Heart Journal 2003;24(11):987-1003.
6. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clininical Trials 1986;7(3):177-88.
7. ESC 2003 De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al.European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Heart Journal 2003;24(117):1601-10.
8. Estabrooks 2001 Estabrooks C, Goel V, Thiel E, Pinfold P, Sawka C, Williams I. Decision aids: are they worth it? A systematic review. Journal of Health Services & Research Policy 2001;6(3):170-82.
9. Meland 1994 Meland E, Laerum E, Lehmann EH. Assessment of coronary heart disease risk, II. A clinical multicentre study of general practitioners' risk assessment. Family Practice 1994;11(2):122-6.
10. NCEP 2002 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421.
11. NSF CHD 2000 Great Britain, Department of Health. National service framework (NSF) for coronary heart disease. London: Department of Health, 2000.
12. Wilson 1998 Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-47.